I am a
Home I AM A Search Login

Papers of the Week

2020 Sep 16

Ann Hepatol

Efficacy and Safety of Glecaprevir/Pibrentasvir in Treatment-Naïve Adults with Chronic Hepatitis C Virus Genotypes 1-6 in Brazil.


Peribañez-Gonzalez M, Cheinquer H, Rodrigues L, Lima M P, Álvares-da-Silva M R, Madruga J, Parise E R, Pessoa M G, Furtado J, Villanova M, Ferreira A, Mazzoleni F, Nascimento E, Silva G F, Fredrick L, Krishnan P, Burroughs M, Reuter T
Ann Hepatol. 2020 Sep 16.
PMID: 32949786.


Glecaprevir/pibrentasvir is a highly effective and well tolerated treatment for hepatitis C infection. Brazilian patients were not included in the original development studies for glecaprevir/pibrentasvir. This study aimed to assess safety and efficacy of glecaprevir/pibrentasvir in treatment-naïve Brazilian adults without cirrhosis or with compensated cirrhosis.